Upregulated miR-144-3p disturbed the MMP-9 pathway by inhibiting Ets1 expression in MSCs, and subsequently impaired the mobilization of EPCs from bone marrow, which provided a novel mechanism underlying diabetes-mediated re-endothelialization dysfunction post myocardial infarction (Figure 7). Here, MMP9 is linked to myocardial infarction.